Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Polyrizon Ltd. announces $4.0 million in a registered direct offering and private placement, closing on September 4, 2026, with a single institutional investor.

PUBLIC · PLRZSep 03, 2026•5 days ago

Amount Raised

$4 Million

Round Type

Seed

Center DistrictBiotechnologyHealth Care

Investors

Single Institutional Investor

Description

Polyrizon Ltd. has entered into definitive agreements for a registered direct offering and concurrent private placement, aiming for approximately $4.0 million in gross proceeds. The transactions involve the sale of Ordinary Shares and pre-funded warrants. The Company plans to utilize the net proceeds from these offerings to advance its development projects

Company Information

Company

Polyrizon Ltd

Location

Center District, Israel

About

Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays. These sprays form a thin hydrogel-based shield that acts as a barrier against viruses and allergens. Polyrizon is focused on creating solutions that improve the intranasal delivery of drugs and alleviate allergy symptoms. Their proprietary hydrogel technology aims to provide rapid relief to those suffering from nasal allergies.

Don't miss Polyrizon Ltd's next move

Get an email the moment Polyrizon Ltd raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
2 contacts
Verified contactsDaphna A., Chief People Officer hidden
Predictive Intelligence
Strategic

ML-powered predictions for Polyrizon Ltd's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Polyrizon Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.